Lumos Pharma, Inc. (LUMO) Social Stream



Lumos Pharma, Inc. (LUMO): $2.45

0.05 (-2.00%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add LUMO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#195 of 347

in industry

LUMOS PHARMA INC (LUMO) Price Targets From Analysts

Use the tables below to see what analysts covering LUMOS PHARMA INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 5 $35 $17 $27.6 $3.06 801.96%
2022-05-11 5 $35 $17 $25 $3.06 716.99%
2022-08-10 6 $31 $17 $23.5 $3.06 667.97%
2022-11-14 6 $31 $17 $23.5 $3.06 667.97%
2022-12-08 6 $31 $7 $21.833 $3.06 613.5%
2023-01-18 5 $28 $7 $18.6 $3.06 507.84%
2023-07-11 5 $28 $4 $18 $3.06 488.24%
2023-08-10 5 $28 $4 $17.8 $3.06 481.7%
2023-08-15 5 $28 $4 $17 $3.06 455.56%
2023-11-08 4 $28 $17 $23.666 $3.06 673.4%
2023-11-09 4 $28 $10 $20.25 $3.06 561.76%
2023-12-10 4 $28 $16 $23.333 $3.06 662.52%

The Trend in the Analyst Price Target


Over the past 36 months, LUMO's average price target has gone down $9.67.

Over the past 47 weeks, LUMO's average upside potential has been 479.81%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-05 5 28 4 18.00 3.49 415.76%
2023-08-10 5 28 4 17.80 2.83 528.98%
2023-08-15 4 28 10 20.25 2.95 586.44%
2023-09-06 4 28 10 20.25 3.38 499.11%
2023-11-09 4 28 10 20.25 3.34 506.29%

LUMO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


LUMO's average broker recommendation rating improved by 0 over the prior 23 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LUMO as an investment opportunity.

  • In terms of how LUMOS PHARMA INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1236.77% of that group.
  • In terms of how LUMOS PHARMA INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 257.69% of that group.
  • LUMO has a lower variance in analysts' estimates than -884.59% of stocks in the small market cap category.
  • To contextualize these metrics, consider that out of Healthcare stocks, LUMOS PHARMA INC's average analyst price target is higher than 485.74% of them.

Stocks similar to LUMOS PHARMA INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CPIX, DRRX, and RMTI.

What is the outlook for LUMO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!